Business Description
Harbin Gloria Pharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000QG8
Share Class Description:
SZSE:002437: Class ACompare
Compare
Traded in other countries / regions
002437.China IPO Date
2010-06-23Description
Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.72 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.31 | |||||
| Interest Coverage | 15.37 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 4.38 | |||||
| Beneish M-Score | -3.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -4.9 | |||||
| 3-Year EBITDA Growth Rate | -26.2 | |||||
| 3-Year Book Growth Rate | -3.5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.09 | |||||
| 9-Day RSI | 53.61 | |||||
| 14-Day RSI | 55.68 | |||||
| 6-1 Month Momentum % | 22.5 | |||||
| 12-1 Month Momentum % | -7.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1 | |||||
| Quick Ratio | 0.78 | |||||
| Cash Ratio | 0.54 | |||||
| Days Inventory | 62.54 | |||||
| Days Sales Outstanding | 27.52 | |||||
| Days Payable | 22.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 14.94 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.96 | |||||
| Operating Margin % | 10.64 | |||||
| Net Margin % | 3.3 | |||||
| FCF Margin % | 9.15 | |||||
| ROE % | 4.42 | |||||
| ROA % | 2.59 | |||||
| ROIC % | 6.86 | |||||
| ROC (Joel Greenblatt) % | 14.79 | |||||
| ROCE % | 8.18 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 68.11 | |||||
| PE Ratio without NRI | 70 | |||||
| Price-to-Owner-Earnings | 119.96 | |||||
| PS Ratio | 2.3 | |||||
| PB Ratio | 3.04 | |||||
| Price-to-Tangible-Book | 4.27 | |||||
| Price-to-Free-Cash-Flow | 24.7 | |||||
| Price-to-Operating-Cash-Flow | 20.48 | |||||
| EV-to-EBIT | 33.95 | |||||
| EV-to-EBITDA | 33.95 | |||||
| EV-to-Revenue | 2.17 | |||||
| EV-to-FCF | 23.41 | |||||
| Price-to-Projected-FCF | 1.07 | |||||
| Price-to-Median-PS-Value | 1.17 | |||||
| Price-to-Graham-Number | 3.65 | |||||
| Earnings Yield (Greenblatt) % | 2.95 | |||||
| FCF Yield % | 3.87 | |||||
| Forward Rate of Return (Yacktman) % | -1.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Harbin Gloria Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,431.537 | ||
| EPS (TTM) (Â¥) | 0.037 | ||
| Beta | 0.91 | ||
| Volatility % | 37.4 | ||
| 14-Day RSI | 55.68 | ||
| 14-Day ATR (Â¥) | 0.109247 | ||
| 20-Day SMA (Â¥) | 2.5345 | ||
| 12-1 Month Momentum % | -7.2 | ||
| 52-Week Range (Â¥) | 1.66 - 2.9 | ||
| Shares Outstanding (Mil) | 2,279.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Harbin Gloria Pharmaceuticals Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Harbin Gloria Pharmaceuticals Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Harbin Gloria Pharmaceuticals Co Ltd Frequently Asked Questions
What is Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437)'s stock price today?
The current price of SZSE:002437 is ¥2.52. The 52 week high of SZSE:002437 is ¥2.90 and 52 week low is ¥1.66.
When is next earnings date of Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437)?
The next earnings date of Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437) is .
Does Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437) pay dividends? If so, how much?
Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers